Duchenne mus­cu­lar dy­s­tro­phy drug flunks Phase 3 con­fir­ma­to­ry tri­al

NS Phar­ma’s Duchenne mus­cu­lar dy­s­tro­phy drug Vil­tep­so failed its con­fir­ma­to­ry study. De­spite the fail­ure, the com­pa­ny is keep­ing faith in the drug and run­ning fur­ther …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER